Finance

Lists
Outlook: 42.9% bullish·3.1% bearish
Go to analysis
C:NYSE
Citigroup Inc.
$123.73
-0.43%
(-0.54) 1D
Oct 19, 11:26:20 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for C...
Open
$124.13
High
$124.81
Low
$123.08
Mkt. cap
204.90B
Avg. vol.
9.99M
Volume
1.33M
Dividend
2.16%
Quarterly dividend
$0.67
Ex-dividend date
Aug 3, 2026
P/E ratio
12.07
52-wk high
$147.96
52-wk low
$95.00
EPS
$10.26
Beta
1.13
Shares outstanding
1.68B
No. of employees
217K
Open
$124.13
High
$124.81
Low
$123.08
Mkt. cap
204.90B
Avg. vol.
9.99M
Volume
1.33M
Dividend
2.16%
Quarterly dividend
$0.67
Ex-dividend date
Aug 3, 2026
P/E ratio
12.07
52-wk high
$147.96
52-wk low
$95.00
EPS
$10.26
Beta
1.13
Shares outstanding
1.68B
No. of employees
217K
News stories
From web sources and news partners
Profile
Citigroup Inc. or Citi is an American multinational investment bank and financial services company based in New York City. The company was formed in 1998 by the merger of Citicorp, the bank holding company for Citibank, and Travelers; Travelers was spun off from the company in 2002. Citigroup is the third-largest banking institution in the United States by assets; alongside JPMorgan Chase, Bank of America, and Wells Fargo, it is one of the Big Four banking institutions of the United States. It is considered a systemically important bank by the Financial Stability Board and is commonly called "too big to fail". It is one of the eight global investment banks in the Bulge Bracket. Citigroup is ranked 36th on the Fortune 500, and was ranked #24 in Forbes Global 2000 in 2023.The company has assets under management of around US$2.8T. Wikipedia
About Citigroup Inc.
CEOJane Fraser
Employees217K
FoundedOct 8, 1998
HeadquartersNew York, New York, United States
SectorBank
Analyst ratings
Based on 17 analysts giving stock ratings to C in the past 3 months
Strong buy
Buy
14
Hold
3
Sell
0
12-month forecast
Based on 17 Wall Street analysts offering 12 month price targets for C in the last 3 months.
Highest
Current $123.73
$165.00 (+33.35%)
Average
$153.00 (+23.66%)
Lowest
$135.00 (+9.11%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jose Luis Pascual
JLPascual
Buy
Maintained
$160.00
+29.3%
10/17/2026
Lim Rui Wen
DBS
Buy
Maintained
$160.00
+29.3%
10/16/2026
Scott Siefers
TD Cowen
Buy
Reiterated
$148.00
+19.6%
10/14/2026
Stephen Biggar
Argus Research
Buy
Reiterated
$150.00
+21.2%
10/13/2026
Glenn Schorr
Evercore ISI
Hold
Maintained
$135.00
+9.1%
10/14/2026
Vivek Juneja
J.P. Morgan
Buy
Maintained
$147.00
+18.8%
10/14/2026
Mike Mayo
Wells Fargo
Buy
Reiterated
$165.00
+33.4%
10/14/2026
Christopher Mcgratty
KBW
Buy
Reiterated
$159.00
+28.5%
10/14/2026
Gerard Cassidy
RBC Capital
Buy
Maintained
$135.00
+9.1%
10/13/2026
Manan Gosalia
Morgan Stanley
Buy
Reiterated
$164.00
+32.5%
10/15/2026
Jason Goldberg
Barclays
Buy
Maintained
$154.00
+24.5%
10/14/2026
Richard Ramsden
Goldman Sachs
Buy
Reiterated
$155.00
+25.3%
10/13/2026
Ebrahim Poonawala
Bank of America Securities
Buy
Reiterated
$160.00
+29.3%
10/13/2026
Unknown Analyst
TD Cowen
Buy
Initiated
$150.00
+21.2%
10/08/2026
Erika Najarian
UBS
Hold
Maintained
$139.00
+12.3%
10/05/2026
Chris Kotowski
Oppenheimer
Hold
Maintained
-
-
10/02/2026
John McDonald CFA
Truist Financial
Buy
Maintained
-
-
09/29/2026
Domenico Santoro
HSBC
Buy
Maintained
$164.00
+32.5%
09/28/2026
David Chiaverini
Jefferies
Buy
Maintained
$165.00
+33.4%
07/15/2026
Unknown Analyst
CFRA
Hold
Downgraded
-
-
05/19/2026
Jia Hui NG
DBS
Buy
Maintained
$160.00
+29.3%
04/14/2026
Saul Martinez
HSBC
Buy
Reiterated
$130.00
+5.1%
03/31/2026
Last report
Oct 13, 2026
Fiscal period
Q3 2026
$2.83 / $2.62
+7.94%beat
Revenue / Est. (USD)
21.42B / 23.72B
-9.68%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
17.66B
22.06B
22.16B
21.42B
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.07B
11.98B
11.60B
11.18B
Operating expense
13.13B
14.54B
14.13B
14.12B
Total operating expenses
13.13B
14.54B
14.13B
14.12B
Operating income
4.53B
7.52B
8.03B
7.31B
Other non operating income
-
-
-
-
EBT including unusual items
3.81B
7.52B
8.03B
7.31B
EBT excluding unusual items
4.53B
7.52B
8.03B
7.31B
Income tax expense
1.29B
1.58B
2.00B
1.89B
Effective tax rate
33.80%
20.99%
24.97%
25.82%
Other operating expenses
2.06B
2.56B
2.53B
2.94B
Net income
2.47B
5.78B
5.83B
5.24B
Net profit margin
14.00%
26.23%
26.31%
24.48%
Earnings per share
1.24
3.06
3.14
2.83
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
1.17B
18.00M
-21.00M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps